Dr. Lucian Dorobantu, Ph. MD.

Senior Cardiovascular Surgeon

2020 World Premiere: Redefining Morphological Criteria in CMHO, Lucian Dorobantu is the co-author of the study “Congenital Muscular Mitral Aortic Discontinuity Identified in Patients with Obstructive Hypertrophic Cardiomyopathy,” published in the Journal of The American College of Cardiology.

Q&A: Is it the extended septal myectomy the right treatment option for you?

We are here to help you understand the disease and to guide you through the steps you need to take in order to live a normal life. Surgery is not always the first line of treatment but it is in many cases the end point. We make sure you get the best medical treatment before and after surgery. In our center we use the innovative Ferrazzi’s technique, performing not only the surgical procedure called “one piece myectomy”, but also repairing the mitral valve by cutting the fibrotic secondary chordae and “reconfiguration” of the left ventricle architecture by operating on the subvalvular apparatus of the mitral valve. Myectomy involves a muscle resection of the septum to widen the left ventricular ejection tract sufficiently and thus reduce the SAM (systolic anterior motion) movement of the mitral valve. The technique involves an “one piece” resection of the septum, whose dimensions are strictly calculated and individually customized using MRI, transesophageal and transthoracic echocardiography, a technique that was published by our team in American Journal of Cardiology in 2019. We speak about a “tailoring surgery” method, personalized to each case. It is par excellence a reconstruction of the left heart ventricle and mitral valve. The fact that in over 98% of cases we preserve the mitral valve is extremely important for the patient and for his long-term quality of life.